Published in Sci Rep on January 23, 2015
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet (2009) 12.96
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet (1999) 5.91
Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A (1996) 5.24
Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience (2006) 2.87
In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry (2004) 2.55
Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol (2000) 2.22
Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry (1998) 1.55
Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res (2011) 1.51
Calcium-binding protein parvalbumin as a neuronal marker. Nature (1981) 1.45
Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain (2009) 1.29
Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex. J Invest Dermatol (2005) 1.17
S100B protein in neurodegenerative disorders. Clin Chem Lab Med (2011) 1.14
Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry (2013) 1.11
Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol (2007) 1.10
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry (2004) 1.08
Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry (2013) 1.07
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry (2001) 1.05
Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Mol Psychiatry (2009) 1.05
Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology (2007) 1.05
A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry (2012) 1.02
Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. Synapse (2000) 1.01
Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol (2011) 1.00
Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry (2013) 1.00
Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry (2011) 0.99
The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Res (2010) 0.99
Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis. Psychiatry Res (2009) 0.99
Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia. Schizophr Res (2003) 0.95
Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia. Schizophr Res (2007) 0.94
Repetin (Rptn), a new member of the "fused gene" subgroup within the S100 gene family encoding a murine epidermal differentiation protein. Genomics (1997) 0.94
Skin calcium-binding protein: distribution in other tissues. Am J Physiol (1983) 0.93
Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry (2008) 0.92
Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol (2013) 0.90
S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study. J Psychiatr Res (2013) 0.89
Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry (2010) 0.89
Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res (2014) 0.87
Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system. PLoS One (2012) 0.87
The hippocampus in schizophrenia. Am J Psychiatry (2004) 0.85
A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia. Schizophr Res (2014) 0.85
S100B and schizophrenia. Psychiatry Clin Neurosci (2013) 0.84
Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One (2011) 0.83
Progressive alterations of hippocampal CA3-CA1 synapses in an animal model of depression. Behav Brain Res (2014) 0.82
Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. Cell Adh Migr (2009) 0.82
Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand (1988) 0.82
The neurobiology of methamphetamine induced psychosis. Front Hum Neurosci (2014) 0.81
Replicated evidence of absence of association between serum S100B and (risk of) psychotic disorder. PLoS One (2013) 0.81
The ventral portion of the CA1 region of the hippocampus and the prefrontal cortex as candidate regions for neuromodulation in schizophrenia. Med Hypotheses (2013) 0.79
The effects of locus coeruleus and norepinephrine in methamphetamine toxicity. Curr Neuropharmacol (2013) 0.79
Possible increase of dopamine-beta-hydroxylase activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study. Psychiatry Res (1989) 0.79
Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly. Mol Psychiatry (2007) 0.79
Prevalence of psychiatric disorders among heroin users who received methadone maintenance therapy in Taiwan. Am J Addict (2014) 0.79
Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. Acta Pharmacol Sin (2011) 0.78
Covert transport dysfunction in the choroid plexus as a possible cause of schizophrenia. Schizophr Bull (1979) 0.78
Choroid plexus calcification as a possible clue of serotonin implication in schizophrenia. Neurosci Lett (1999) 0.78
The new pattern of drug abuse in China. Curr Opin Psychiatry (2014) 0.78
Choroid plexus calcification: clinical, neuroimaging and histopathological correlations in schizophrenia. Rom J Morphol Embryol (2013) 0.78
Choroid plexus calcification as a possible marker of hallucinations in schizophrenia. Int J Neurosci (1993) 0.77
Calcification of the choroid plexus as a marker of depression in schizophrenia. Schizophr Res (1991) 0.77
Elucidating the pathogenesis of schizophrenia. BMJ (2003) 0.76